English 
Spanish 
3 min read
7 comments
Novo Nordisk's investment in Montes Claros will generate many jobs at its factory and expand the production of enzymes for medicines.
The Government of Minas Gerais announced the expansion of a factory of enzymes in Montes Claros, in the North of Minas Gerais. Novo Nordisk, a Danish pharmaceutical company, will invest R$500 million to expand the production of enzymes, such as enterokinase and ALP, essential for the manufacture of medications such as insulin. The expansion will create 400 new jobs, in addition to strengthening the factory's production and meeting the growing global demand for medications.
Factory expansion and the creation of new jobs
The governor of Minas Gerais, Romeu Zema, celebrated the investment, highlighting the importance of the factory's expansion for the growth of the local economy and for the generation of more jobs.
The expansion of factory will be crucial for Montes Claros, which will become a strategic hub for the production of enzymes and medicines in Brazil and the world.
- Anvisa bans the sale of famous brand powdered milk in all supermarkets in Brazil due to irregularities that put consumers on alert!
- Companies in Japan are offering free housing and college to attract Generation Z amid a low birth rate crisis that is redefining the country's future!
- European industry in collapse: The hidden truth about the waste that exploded in 2018 and still devastates the world
- BNDES and Finep lead R$5 billion financing to boost strategic minerals in Brazil
Zema reinforced that the expansion of the factory will bring not only new jobs, but also a significant contribution to increasing exports and strengthening the local economy.
With the expansion of the enzyme plant, Novo Nordisk will contribute to the creation of approximately 400 indirect jobs, in addition to 40 direct jobs.
The enzyme factory in Montes Claros, with its production focused on insulin and other medicines, will be an important driver for the local job market.
The government of Minas Gerais believes that the expansion of the enzyme factory will bring great benefits not only to the city, but also to the region, generating new jobs and strengthening the economy of Northern Minas.
The Secretary of State for Economic Development, Fernando Passalio, commented on the positive impact that the expansion of the factory will have on the creation of jobs.
He highlighted that, through strategic efforts, the investment was guaranteed, with the enzyme factory representing a great opportunity for Montes Claros to consolidate itself as an important hub in the production of medicines, in addition to creating more jobs.
The role of enzymes in drug production
The production of enzymes such as enterokinase and ALP will be expanded with the expansion of the plant. These enzymes are essential for the production of medicines, such as insulin, that treat chronic diseases such as diabetes and obesity.
A factory The enzyme plant in Montes Claros plays a crucial role in supplying these enzymes to the global market, and the expansion will allow us to further increase production capacity, meeting the growing demand.
Reinaldo Costa, corporate vice president of Novo Nordisk in Montes Claros, explained that the expansion of the enzyme factory will help the company expand drug production.
“With increased enzyme production, we will be able to meet the growing demand for innovative treatments and save more lives,” he said.
The enzyme factory in Montes Claros will therefore be a fundamental element in the process of expanding the production of essential medicines for the treatment of various diseases.
The expansion of the enzyme factory in Montes Claros will bring benefits not only for the production of medicines, but also for the generation of jobs.
The expansion of factory of enzymes will be a milestone for the city, with the creation of new jobs and the strengthening of the local pharmaceutical sector.
Montes Claros, with the increase in the production of enzymes and medicines, will consolidate itself as an important center of production and innovation in Brazil.
The R$500 million investment will allow Novo Nordisk to significantly expand the factory's capacity and generate new jobs for the local population.
Good Morning !
Will there be job openings for retirees?
If it's true, I'm already packing my bags as fast as I can and leaving this wild west of Rio!
Yes, it's true, welcome to Montes Claros